The landscape of mitochondrial DNA variation in human colorectal cancer on the background of phylogenetic knowledge

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1825, Issue 2, 2012, Pages 153-159

  Skonieczna, Katarzyna ^a,b   Malyarchuk, Boris A ^c   Grzybowski, Tomasz ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c INSTITUTE OF BIOLOGICAL PROBLEMS OF THE NORTH   (Russian Federation)

Author keywords

Colorectal cancer; Human mitochondrial phylogeny; Mitochondrial D310 mutations; Mitochondrial DNA haplogroup; Mitochondrial DNA hereditary mutations; Mitochondrial DNA somatic mutations

Indexed keywords

MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE;

CANCER CELL; CANCER GROWTH; CANCER RESEARCH; CANCER RISK; CARCINOGENESIS; CLINICAL PRACTICE; COLORECTAL CANCER; DNA DAMAGE; DNA POLYMORPHISM; DNA SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MICROSATELLITE INSTABILITY; MITOCHONDRIAL GENETICS; MITOCHONDRIAL GENOME; MOLECULAR PATHOLOGY; MUTAGENESIS; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION;

COLORECTAL NEOPLASMS; DNA, MITOCHONDRIAL; DNA, NEOPLASM; GENETIC VARIATION; GENOME, MITOCHONDRIAL; HUMANS; MITOCHONDRIA; PHYLOGENY; SEQUENCE ANALYSIS, DNA;

EID: 84455200476     PISSN: 0304419X     EISSN: 18792561     Source Type: Journal    
DOI: 10.1016/j.bbcan.2011.11.004     Document Type: Review

References (75)

1. Kennedy E.P., Lehninger A.L. Intracellular structures and the fatty acid oxidase system of rat liver. J. Biol. Chem. 1948, 172:847-848.
2. Bao Q., Shi Y. Apoptosome: a platform for the activation of initiator caspases. Cell Death Differ. 2007, 14:56-65.
3. Liu X., Kim C.N., Yang J., Jemmerson R., Wang X. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 1996, 86:147-157.
4. Marchetti P., Castedo M., Susin S.A., et al. Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med. 1996, 184:1155-1160.
5. Zamzami N., Susin S.A., Marchetti P., et al. Mitochondrial control of nuclear apoptosis. J. Exp. Med. 1996, 183:1533-1544.
6. Marchenko N.D., Zaika A., Moll U.M. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J. Biol. Chem. 2000, 275:16202-16212.
7. Chipuk J.E., Kuwana T., Bouchier-Hayes L., et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004, 303:1010-1014.
8. Brandon M., Baldi P., Wallace D.C. Mitochondrial mutations in cancer. Oncogene 2006, 25:4647-4662.
9. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 2005, 39:359-407.
10. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
11. Astuti D., Latif F., Dallol A., et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am. J. Hum. Genet. 2001, 69:49-54.
12. Vanharanta S., Buchta M., McWhinney S.R., et al. Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. Am. J. Hum. Genet. 2004, 74:153-159.
13. Baysal B.E., Ferrell R.E., Willett-Brozick J.E., et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000, 287:848-851.
14. Niemann S., Müller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat. Genet. 2000, 26:268-270.
15. Sánchez-Aragó M., Chamorro M., Cuezva J.M. Selection of cancer cells with repressed mitochondria triggers colon cancer progression. Carcinogenesis 2010, 31:567-576.
16. Anderson S., Bankier A.T., Barrell B.G., et al. Sequence and organization of the human mitochondrial genome. Nature 1981, 290:457-465.
17. Arnold R.S., Sun C.Q., Richards J.C., et al. Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment. Prostate 2009, 69:1-11.
18. Ishikawa K., Takenaga K., Akimoto M., et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 2008, 320:661-664.
19. Ishikawa K., Koshikawa N., Takenaga K., Nakada K., Hayashi J.I. Reversible regulation of metastasis by ROS-generating mtDNA mutations. Mitochondrion 2008, 8:339-344.
20. Petros J.A., Baumann A.K., Ruiz-Pesini E., et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:719-724.
21. Shidara Y., Yamagata K., Kanamori T., et al. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res. 2005, 65:1655-1663.
22. Bandelt H.J., Kong Q.P., Parson W., Salas A. More evidence for non-maternal inheritance of mitochondrial DNA?. J. Med. Genet. 2005, 42:957-960.
23. Bandelt H.J., Salas A. Contamination and sample mix-up can best explain some patterns of mtDNA instabilities in buccal cells and oral squamous cell carcinoma. BMC Cancer 2009, 9:113.
24. Bandelt H.J., Salas A. Current Next Generation Sequencing technology may not meet forensic standards. Forensic Sci. Int. Genet. May 10 2011, [Epub ahead of print]. 10.1016/j.fsigen.2011.04.004.
25. Salas A., Yao Y.G., Macaulay V., Vega A., Carracedo A., Bandelt H.J. A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med. 2005, 2:e296.
26. Yao Y.G., Bandelt H.J., Young N.S. External contamination in single cell mtDNA analysis. PLoS One 2007, 2:e681.
27. Andrews R.M., Kubacka I., Chinnery P.F., Lightowlers R.N., Turnbull D.M., Howell N. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat. Genet. 1999, 23:147.
28. Brown W.M., George M.J., Wilson A.C. Rapid evolution of animal mitochondrial DNA. Proc. Natl. Acad. Sci. U. S. A. 1979, 76:1967-1971.
29. Brown W.M., Prager E.M., Wang A., Wilson A.C. Mitochondrial DNA sequences of primates: tempo and mode of evolution. J. Mol. Evol. 1982, 18:225-239.
30. Richter C., Park J.W., Ames B.N. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:6465-6467.
31. Malyarchuk B.A., Rogozin I.B., Berikov V.B., Derenko M.V. Analysis of phylogenetically reconstructed mutational spectra in human mitochondrial DNA control region. Hum. Genet. 2002, 111:46-53.
32. Malyarchuk B.A. Distribution of Nucleotide Substitutions in Human Mitochondrial DNA Genes. Russ. J. Genet. 2005, 41:93-99.
33. Malyarchuk B.A. "Cold" spots in hypervariable segment 1 of human mitochondrial DNA. Mol. Biol. 2008, 42:399-402.
34. Pereira L., Freitas F., Fernandes V., et al. The diversity present in 5140 human mitochondrial genomes. Am. J. Hum. Genet. 2009, 84:628-640.
35. Soares P., Ermini L., Thomson N., et al. Correcting for purifying selection: an improved human mitochondrial molecular clock. Am. J. Hum. Genet. 2009, 84:740-759.
36. van Oven M., Kayser M. Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum. Mutat. 2009, 30:E386-E394.
37. Brown W.M. Polymorphism in mitochondrial DNA of humans as revealed by restriction endonuclease analysis. Proc. Natl. Acad. Sci. U. S. A. 1980, 77:3605-3609.
38. Giles R.E., Blanc H., Cann H.W., Wallace D.C. Maternal inheritance of human mitochondrial DNA. Proc. Natl. Acad. Sci. U. S. A. 1980, 77:6715-6719.
39. Bandelt H.J., Richards M., Macaulay M. Human Mitochondrial DNA and the Evolution of Homo Sapiens 2006, Springer, Berlin Heidelberg, New York. first ed.
40. Wiseman H., Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 1996, 313:17-29.
41. Malyarchuk B.A., Rogozin I.B. Mutagenesis by transient misalignment in the human mitochondrial DNA control region. Ann. Hum. Genet. 2004, 68:324-339.
42. Webb E., Broderick P., Chandler I., et al. Comprehensive analysis of common mitochondrial DNA variants and colorectal cancer risk. Br. J. Cancer 2008, 99:2088-2093.
43. Theodoratou E., Din F.V.N., Farrington S.M., et al. Association between common mtDNA variants and all-cause or colorectal cancer mortality. Carcinogenesis 2009, 31:296-301.
44. Fang H., Shen L., Chen T., et al. Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer. BMC Cancer 2010, 10:421.
45. Samuels D.C., Carothers A.D., Horton R., Chinnery P.F. The power to detect disease associations with mitochondrial DNA haplogroups. Am. J. Hum. Genet. 2006, 78:713-720.
46. Habano W., Nakamura S., Sugai T. Microsatellite instability in the mitochondrial DNA of colorectal carcinomas: evidence for mismatch repair systems in mitochondrial genome. Oncogene 1998, 17:1931-1937.
47. Guleng G., Løvig T., Meling G.I., Andersen S.N., Rognum T.O. Mitochondrial microsatellite instability in colorectal carcinomas-frequency and association with nuclear microsatellite instability. Cancer Lett. 2005, 219:97-103.
48. Lièvre A., Chapusot C., Bouvier A.M., et al. Clinical value of mitochondrial mutations in colorectal cancer. J. Clin. Oncol. 2005, 23:3517-3525.
49. Kim H.S., Lim H.S., Lee S.H., et al. Mitochondrial microsatellite instability of colorectal cancer stroma. Int. J. Cancer 2006, 119:2607-2611.
50. Legras A., Lièvre A., Bonaiti-Pellié C., et al. Mitochondrial D310 mutations in colorectal adenomas: an early but not causative genetic event during colorectal carcinogenesis. Int. J. Cancer 2008, 122:2242-2248.
51. Chang S.C., Lin P.C., Yang S.H., Wang H.S., Liang W.Y., Lin J.K. Mitochondrial D-loop mutation is a common event in colorectal cancers with p53 mutations. Int. J. Colorectal Dis. 2009, 24:623-628.
52. Singh K.K., Ayyasamy V., Owens K.M., Koul M.S., Vujcic M. Mutations in mitochondrial DNA polymerase-gamma promote breast tumorigenesis. J. Hum. Genet. 2009, 54:516-524.
53. Polyak K., Li Y., Zhu H., et al. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat. Genet. 1998, 20:291-293.
54. Lorenc A., Bryk J., Golik P., et al. Homoplasmic MELAS A3243G mtDNA mutation in a colon cancer sample. Mitochondrion 2003, 3:119-124.
55. Yusnita Y., Norsiah M.D., Rahman A.J. Mutations in mitochondrial NADH dehydrogenase subunit 1 (mtND1) gene in colorectal carcinoma. Malays. J. Pathol. 2010, 32:103-110.
56. Akouchekian M., Houshmand M., Akbari M.H., Kamalidehghan B., Dehghan M. Analysis of mitochondrial ND1 gene in human colorectal cancer. J. Res. Med. Sci. 2011, 16:50-55.
57. Quintana-Murci L., Chaix R., Wells R.S., et al. Where west meets east: the complex mtDNA landscape of the southwest and Central Asian corridor. Am. J. Hum. Genet. 2004, 74:827-845.
58. Derenko M., Malyarchuk B., Grzybowski T., et al. Phylogeographic analysis of mitochondrial DNA in northern Asian populations. Am. J. Hum. Genet. 2007, 81:1025-1041.
59. Wang C.Y., Li H., Hao X.D., et al. Uncovering the profile of somatic mtDNA mutations in Chinese colorectal cancer patients. PLoS One 2011, 6:e21613.
60. He Y., Wu J., Dressman D.C., et al. Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature 2010, 464:610-614.
61. Pereira L., Soares P., Radivojac P., Li B., Samuels D.C. Comparing phylogeny and the predicted pathogenicity of protein variations reveals equal purifying selection across the global human mtDNA diversity. Am. J. Hum. Genet. 2011, 88:433-439.
62. Irwin J.A., Saunier J.L., Niederstätter H., et al. Investigation of heteroplasmy in the human mitochondrial DNA control region: a synthesis of observations from more than 5000 global population samples. J. Mol. Evol. 2009, 68:516-527.
63. Tully L.A., Parsons T.J., Steighner R.J., et al. A Sensitive Denaturing Gradient-Gel Electrophoresis Assay Reveals a High Frequency of Heteroplasmy in Hypervariable Region 1 of the Human mtDNA Control Region. Am. J. Hum. Genet. 2000, 67:432-443.
64. Wang C.Y., Wang H.W., Yao Y.G., Kong Q.P., Zhang Y.P. Somatic mutations of mitochondrial genome in early stage breast cancer. Int. J. Cancer 2007, 121:1253-1256.
65. Fendt L., Niederstätter H., Huber G., et al. Accumulation of mutations over the entire mitochondrial genome of breast cancer cells obtained by tissue microdissection. Breast Cancer Res. Treat. 2011, 128:327-336.
66. Kloss-Brandstätter A., Schäfer G., Erhart G., et al. Somatic mutations throughout the entire mitochondrial genome are associated with elevated PSA levels in prostate cancer patients. Am. J. Hum. Genet. 2010, 87:802-812.
67. Schönberg A., Theunert C., Li M., Stoneking M., Nasidze I. High-throughput sequencing of complete human mtDNA genomes from the Caucasus and West Asia: high diversity and demographic inferences. Eur. J. Hum. Genet. Apr 13 2011, [Epub ahead of print]. 10.1038/ejhg.2011.62.
68. Chihara N., Amo T., Tokunaga A., et al. Mitochondrial DNA alterations in colorectal cancer cell lines. J. Nippon Med. Sch. 2011, 78:13-21.
69. Bandelt H.J., Achilli A., Kong Q.P., et al. Low "penetrance" of phylogenetic knowledge in mitochondrial disease studies. Biochem. Biophys. Res. Commun. 2005, 333:122-130.
70. Bandelt H.J., Lahermo P., Richards M., Macaulay V. Detecting errors in mtDNA data by phylogenetic analysis. Int. J. Legal Med. 2001, 115:64-69.
71. Bandelt H.J., Salas A., Bravi C.M. What is a 'novel' mtDNA mutation-and does 'novelty' really matter?. J. Hum. Genet. 2006, 51:1073-1082.
72. Czarnecka A.M., Krawczyk T., Czarnecki J.S., et al. Methodology for mitochondrial DNA research in oncology: goals and pitfalls. A.R.S. Med. Tomitana 2008, 14:48-64.
73. Salas A., Carracedo A., Macaulay V., Richards M., Bandelt H.J. A practical guide to mitochondrial DNA error prevention in clinical, forensic, and population genetics. Biochem. Biophys. Res. Commun. 2005, 335:891-899.
74. Kloss-Brandstätter A., Pacher D., Schönherr S., Weissensteiner H., Binna R., Specht G., Kronenberg F. HaploGrep: a fast and reliable algorithm for automatic classification of mitochondrial DNA haplogroups. Hum. Mutat. 2011, 32:25-32.
75. Pereira L., Gonçalves J., Goios A., Rocha T., Amorim A. Human mtDNA haplogroups and reduced male fertility: real association or hidden population substructuring. Int. J. Androl. 2005, 28:241-247.